Cibc World Markets Corp Novavax Inc Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Novavax Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 14,426 shares of NVAX stock, worth $118,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,426Holding current value
$118,148% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
284Shares Held
95MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$126 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$97 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$91.3 Million35.54% of portfolio
-
State Street Corp Boston, MA7.69MShares$63 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$48.6 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $641M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...